Vice President, BioPharmaceuticals Compliance
Barbara leads the compliance program across the US and several global functions and serves as a member of the US Leadership Team, Global Ethics and Transparency Team, and the Safety/Health/Environment Executive Committee. She also leads the US Compliance & Ethics Leadership Team and sponsored the creation of Universal Language Standards to ensure that complex healthcare topics can be more easily understood and accessed by patients.
Barbara has led high-performing teams since joining AstraZeneca in 2005. She is passionate about cultivating talent and developing others, as well as influencing our sustainability strategy. In her most recent role as Americas Assurance Lead, Barbara transformed the assurance program for Latin America and the United States.
Prior to her global role, Barbara managed an optimized speaker program strategy across the enterprise. She provided oversight for audit activities and was Secretariat to the Compliance and Ethics Leadership Team. Additionally, she formed the first Healthcare Compliance Committee Review Board.
Barbara started her AstraZeneca career in Operations managing drug sample programs, a role she similarly held at Wyeth. Earlier in her career, Barbara held various positions with DuPont Merck, including sales representative and business services director.
- Business Management degree, Wilmington University
- Board member of the Delaware Chamber of Commerce
- Member of the Pharmaceutical Research and Manufacturers of America
- Member of the International Federation of Pharmaceutical Manufacturers and Associations
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.